【摘要】：在社會主義市場經(jīng)濟(jì)體制不夠完善的條件下,醫(yī)藥行業(yè)市場經(jīng)濟(jì)秩序混亂,造成以商業(yè)賄賂為代表的各種不正當(dāng)競爭行為持續(xù)蔓延。商業(yè)賄賂直接影響了醫(yī)療服務(wù)水平與衛(wèi)生事業(yè)發(fā)展,事關(guān)老百姓的切身利益,日益成為全民熱議的焦點(diǎn)話題。要從根本上治理醫(yī)藥行業(yè)商業(yè)賄賂,就要對現(xiàn)行的治理措施進(jìn)行反思,找出問題,通過借鑒一些國際治理經(jīng)驗(yàn),提出適合中國的醫(yī)藥行業(yè)商業(yè)賄賂治理方式。 醫(yī)藥行業(yè)商業(yè)賄賂的治理進(jìn)程可以分為事前、事中、事后三個階段,每個階段存在著不同的問題。事前階段醫(yī)療服務(wù)體制不合理,醫(yī)藥市場機(jī)制不暢,相關(guān)法律法規(guī)缺失；事中階段政府的指導(dǎo)工作不到位,工商行政執(zhí)法部門職能缺位；事后階段司法部門重視程度不足,處罰力度過輕,標(biāo)準(zhǔn)不一。其原因主要包括,政府財(cái)政投入不足、現(xiàn)行法律法規(guī)效力不理想、市場準(zhǔn)入把關(guān)不嚴(yán)、藥品集中招標(biāo)采購不規(guī)范、收入分配制度不合理、公眾重視程度不足六個方面。通過構(gòu)建治理長效機(jī)制來防治醫(yī)藥行業(yè)商業(yè)賄賂行為,具體分為制度、法律、教育并重的預(yù)防機(jī)制,醫(yī)藥產(chǎn)業(yè)發(fā)展的調(diào)控機(jī)制,醫(yī)藥行業(yè)監(jiān)督制約機(jī)制,以及以政府為主導(dǎo)的多元化治理體系。
[Abstract]:Under the condition that the socialist market economy system is not perfect, the order of the medicine market economy is in disorder, resulting in various unfair competition behaviors represented by commercial bribery continue to spread. Commercial bribery has directly affected the level of medical service and the development of health care, which concerns the vital interests of the common people, and has increasingly become a hot topic of discussion among the whole people. In order to deal with the commercial bribery in medicine industry fundamentally, we should reflect on the existing measures, find out the problems, and put forward the management mode of commercial bribery suitable for China through drawing lessons from some international governance experiences. The governance process of commercial bribery in pharmaceutical industry can be divided into three stages: beforehand, during, and afterwards, each stage has its own problems. In advance, the medical service system is unreasonable, the medical market mechanism is not smooth, the relevant laws and regulations are missing; the guiding work of the government is not in place and the functions of the administrative law enforcement departments for industry and commerce are not in place at the middle stage of the incident; the judicial departments pay less attention to it after the event. The punishment was too light and varied in standard. The main reasons include inadequate government financial investment, imperfect effectiveness of current laws and regulations, inadequate market access control, non-standard centralized bidding and procurement of drugs, unreasonable income distribution system, and insufficient public attention in six aspects. To prevent and control commercial bribery in the pharmaceutical industry through the construction of a long-term mechanism of governance, it can be divided into two parts: prevention mechanism with equal emphasis on system, law and education, regulation and control mechanism for the development of pharmaceutical industry, supervision and restriction mechanism of pharmaceutical industry. And the government-led pluralistic governance system.
【學(xué)位授予單位】：天津師范大學(xué)
【學(xué)位級別】：碩士
【學(xué)位授予年份】：2015
【分類號】：D922.294

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 嚴(yán)波;;治理商業(yè)賄賂與構(gòu)建公共行政倫理體系[J];中國城市經(jīng)濟(jì);2011年12期

2 曾衛(wèi)龍;李妮亞;朱艷華;李凌燕;潘強(qiáng);;在防治醫(yī)藥商業(yè)賄賂中醫(yī)院過度用藥對策研究[J];當(dāng)代醫(yī)學(xué);2009年32期

3 張麗琴;;淺析醫(yī)藥行業(yè)商業(yè)賄賂腐敗現(xiàn)象及治理對策[J];法制與經(jīng)濟(jì)(下旬刊);2009年02期

4 錢勇濤;;醫(yī)藥商業(yè)賄賂成因及對策[J];法制與社會;2010年24期

5 儲成鵬;;試論我國藥品商業(yè)賄賂法律規(guī)制[J];法制與社會;2011年15期

6 徐向業(yè);;略談商業(yè)賄賂犯罪的危害和打擊對策[J];法制與社會;2011年30期

7 柏巖;;論醫(yī)藥購銷領(lǐng)域商業(yè)賄賂的現(xiàn)狀與對策[J];遼寧公安司法管理干部學(xué)院學(xué)報(bào);2009年04期

8 徐玉立;;當(dāng)代醫(yī)院商業(yè)賄賂發(fā)生原因與治理措施之探討[J];中國社會醫(yī)學(xué)雜志;2012年03期

9 董書平;;治理醫(yī)藥衛(wèi)生領(lǐng)域商業(yè)賄賂的對策研究[J];醫(yī)院管理論壇;2013年10期

10 李建華;田贊;田暉;;在華跨國商業(yè)賄賂的根源與治理對策研究——葛蘭素史克案反思[J];東南學(xué)術(shù);2014年02期

，

本文編號：2238710